Providence Wealth Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.27M | Buy |
6,063
+270
| +5% | +$92.4K | 1.34% | 22 |
|
|
2026
Q1 | $2.04M | Buy |
5,793
+49
| +0.9% | +$17.5K | 1.3% | 26 |
|
|
2025
Q4 | $1.83M | Buy |
5,744
+35
| +0.6% | +$11.1K | 1.14% | 24 |
|
|
2025
Q3 | $1.67M | Sell |
5,709
-45
| -0.8% | -$13.1K | 1.05% | 31 |
|
|
2025
Q2 | $1.64M | Buy |
5,754
+120
| +2% | +$34K | 1.13% | 31 |
|
|
2025
Q1 | $1.72M | Buy |
5,634
+63
| +1% | +$18.6K | 1.31% | 26 |
|
|
2024
Q4 | $1.44M | Buy |
5,571
+50
| +0.9% | +$14.8K | 1.09% | 28 |
|
|
2024
Q3 | $1.74M | Buy |
5,521
+110
| +2% | +$36K | 1.29% | 24 |
|
|
2024
Q2 | $1.7M | Buy |
5,411
+120
| +2% | +$35.3K | 1.36% | 23 |
|
|
2024
Q1 | $1.47M | Buy |
5,291
+3,165
| +149% | +$926K | 1.25% | 25 |
|
|
2023
Q4 | $2.65M | Sell |
2,126
-2,781
| -57% | -$758K | 2.39% | 9 |
|
|
2023
Q3 | $1.3M | Buy |
4,907
+80
| +2% | +$20K | 1.45% | 25 |
|
|
2023
Q2 | $1.09M | Sell |
4,827
-315
| -6% | -$73.1K | 1.21% | 29 |
|
|
2023
Q1 | $1.26M | Buy |
5,142
+40
| +0.8% | +$9.82K | 0.93% | 38 |
|
|
2022
Q4 | $1.36M | Buy |
5,102
+125
| +3% | +$33.5K | 1.01% | 35 |
|
|
2022
Q3 | $1.47M | Sell |
4,977
-192
| -4% | -$46.5K | 1.09% | 31 |
|
|
2022
Q2 | $1.27M | Buy |
5,169
+419
| +9% | +$103K | 0.92% | 36 |
|
|
2022
Q1 | $1.16M | Buy |
4,750
+96
| +2% | +$22.1K | 0.74% | 44 |
|
|
2021
Q4 | $1.07M | Buy |
4,654
+10
| +0.2% | +$2.11K | 0.67% | 49 |
|
|
2021
Q3 | $991K | Buy |
4,644
+15
| +0.3% | +$3.45K | 0.69% | 46 |
|
|
2021
Q2 | $1.14M | Sell |
4,629
-4
| -0.1% | -$984 | 0.78% | 43 |
|
|
2021
Q1 | $1.15M | Buy |
4,633
+225
| +5% | +$53.7K | 0.85% | 42 |
|
|
2020
Q4 | $1M | Buy |
4,408
+226
| +5% | +$52.1K | 0.83% | 43 |
|
|
2020
Q3 | $1.06M | Buy |
4,182
+758
| +22% | +$188K | 1.05% | 35 |
|
|
2020
Q2 | $808K | Buy |
3,424
+140
| +4% | +$31.9K | 0.82% | 42 |
|
|
2020
Q1 | $659K | Buy |
3,284
+75
| +2% | +$16.4K | 0.8% | 44 |
|
|
2019
Q4 | $770K | Sell |
3,209
-400
| -11% | -$88.2K | 0.71% | 52 |
|
|
2019
Q3 | $698K | Buy |
3,609
+35
| +1% | +$6.72K | 0.62% | 54 |
|
|
2019
Q2 | $659K | Buy |
3,574
+35
| +1% | +$6.27K | 0.61% | 55 |
|
|
2019
Q1 | $677K | Buy |
3,539
+147
| +4% | +$28.1K | 0.64% | 54 |
|
|
2018
Q4 | $647K | Hold |
3,392
| – | – | 0.72% | 48 |
|
|
2018
Q3 | $703K | Sell |
3,392
-4
| -0.1% | -$788 | 0.64% | 51 |
|
|
2018
Q2 | $627K | Buy |
3,396
+55
| +2% | +$9.73K | 0.61% | 57 |
|
|
2018
Q1 | $555K | Buy |
+3,341
| New | +$613K | 0.82% | 47 |
|
Other funds holding AMGN
Providence Wealth Advisors's AMGN Position: Q2 2026 in Review
Providence Wealth Advisors increased its Amgen (AMGN) stake by 4.7% in Q2 2026, buying an estimated $92.4K and bringing the position to 6,063 shares worth $2.27M. The position accounts for 1.34% of the portfolio, ranked #22.
Providence Wealth Advisors first reported a position in AMGN in Q1 2018 and has held it in 34 quarters since. The position peaked at $2.65M in Q4 2023. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Providence Wealth Advisors held 6,063 shares of Amgen worth $2.27M as of Q2 2026.
- Providence Wealth Advisors bought 270 Amgen shares in Q2 2026, an estimated $92.4K.
- Amgen made up 1.34% of Providence Wealth Advisors's portfolio in Q2 2026, its #22 holding.
- Providence Wealth Advisors first reported a position in Amgen in Q1 2018 and has held it in 34 quarters since.
- Providence Wealth Advisors's Amgen position peaked at $2.65M in Q4 2023.
- 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Providence Wealth Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.